Literature DB >> 22722066

An overview of renal cell cancer: pathology and genetics.

Holger Moch1.   

Abstract

Renal cell carcinoma is a group of malignancies arising from the epithelium of the renal tubules. The pattern of somatic mutations in kidney tumors has been extensively investigated. In the current 2004 WHO classification, the molecular background of a renal tumor has become, in addition to histopathology, a major criterion for tumor classification. The goal of this review is to discuss morphology and genetics of adult renal epithelial cancer included in the 2004 WHO classification and to mention renal tumor types, which are not considered in the current WHO classification. Further, pathologic considerations with clinical and prognostic implications are provided.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722066     DOI: 10.1016/j.semcancer.2012.06.006

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  38 in total

1.  Association of genetic variations in RTN4 3'-UTR with risk for clear cell renal cell carcinoma.

Authors:  Yan Pu; Peng Chen; Bin Zhou; Peng Zhang; Yanyun Wang; Yaping Song; Lin Zhang
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

2.  Association of Abl interactor 2, ABI2, with platelet/lymphocyte ratio in patients with renal cell carcinoma: A pilot study.

Authors:  Sercan Ergun; Sezgin Gunes; Recep Buyukalpelli; Oguz Aydin
Journal:  Int J Exp Pathol       Date:  2020-06-04       Impact factor: 1.925

3.  Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.

Authors:  Ana Sílvia Pires-Luís; Márcia Vieira-Coimbra; Filipa Quintela Vieira; Pedro Costa-Pinheiro; Rui Silva-Santos; Paula C Dias; Luís Antunes; Francisco Lobo; Jorge Oliveira; Céline S Gonçalves; Bruno M Costa; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  IL-8 induces the epithelial-mesenchymal transition of renal cell carcinoma cells through the activation of AKT signaling.

Authors:  Nan Zhou; Fuding Lu; Cheng Liu; Kewei Xu; Jian Huang; Dexin Yu; Liangkuan Bi
Journal:  Oncol Lett       Date:  2016-07-21       Impact factor: 2.967

Review 5.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 6.  [Renal cancer biomarkers. What is justified?].

Authors:  H Moch
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

7.  Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma.

Authors:  José-Antonio Ortiz-Rey; Carmen Fachal; Laura Juaneda-Magdalena; Mónica Muñoz-Martín; Alfredo Repáraz-Andrade; Susana Teijeira; José-María Lamas-Barreiro; Sheila Almuster-Domínguez; Pilar San Miguel-Fraile; Carolina Gómez-de María
Journal:  Virchows Arch       Date:  2021-01-14       Impact factor: 4.064

8.  Prognostic significance of MST1R dysregulation in renal cell tumors.

Authors:  Ana S Pires-Luís; Márcia Vieira-Coimbra; Maria João Ferreira; João Ramalho-Carvalho; Pedro Costa-Pinheiro; Luís Antunes; Paula C Dias; Francisco Lobo; Jorge Oliveira; Inês Graça; Rui Henrique; Carmen Jerónimo
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

9.  miR-216a-5p acts as an oncogene in renal cell carcinoma.

Authors:  Peijie Chen; Jing Quan; Lu Jin; Canbin Lin; Weijie Xu; Jinling Xu; Xin Guan; Zebo Chen; Liangchao Ni; Shangqi Yang; Yun Chen; Yongqing Lai
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

Review 10.  DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.

Authors:  Javier C Angulo; Jose I López; Santiago Ropero
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.